CONNECTIVE TISSUE DISEASES Trial of SLE therapies in real-world settings

TY - JOUR

T1 - CONNECTIVE TISSUE DISEASES Trial of SLE therapies in real-world settings

AU - Ramos-Casals, Manuel

AU - Khamashta, Munther A.

PY - 2012/3

Y1 - 2012/3

N2 - Allocation of therapy for systemic lupus erythematosus (SLE) remains complex, as most drugs used to treat this disease are used off-label-a situation compounded by the emergence of new therapeutics. In this rapidly changing clinical setting, organ-specific therapeutic guidelines might be useful for 'real world' management of patients with SLE.

AB - Allocation of therapy for systemic lupus erythematosus (SLE) remains complex, as most drugs used to treat this disease are used off-label-a situation compounded by the emergence of new therapeutics. In this rapidly changing clinical setting, organ-specific therapeutic guidelines might be useful for 'real world' management of patients with SLE.

U2 - 10.1038/nrrheum.2012.4

DO - 10.1038/nrrheum.2012.4

M3 - Editorial

VL - 8

SP - 128

EP - 130

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 3

ER -